Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer...(patients. Axona addresses the hypometab...)

Date:7/14/2009

patients. Axona addresses the hypometabolism or defective metabolism of glucose that occurs in those areas of the brain that are involved in Alzheimer's disease. Accera engages in research, development and commercialization of other clinical applications for Axona.

For more information about Accera, please visit www.accerapharma.com.

    Contacts:
    Accera, Inc.
    Steve Orndorff, Ph.D.
    President and CEO
    sorndorff@accerapharma.com

    Richard Lewis Communications, Inc.
    (212) 827-0020
    Andrew Mielach, Media
    amielach@rlcinc.com
    Cecelia Heer, Investors
    cheer@rlcinc.com

'/>"/>

SOURCE Accera, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
2. Evidence of macroscopic quantum tunneling detected in nanowires
3. CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems
4. MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of States Growing Awareness of Industrys Economic Importance
5. ULURU to Present Clinical Evidence and Advanced Research on Altrazeal at the Society for Advance Wound Care Conference for 2009
6. Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
7. Evidence of Ancient Hot Springs on Mars Detailed in Astrobiology Journal
8. Cancer Clinics of Excellence (CCE) Releases 62nd Evidence-Based Treatment Protocol
9. The Lancets New Online Medical Journal Helps Clinicians and Medical Researchers Find Practice-Changing Evidence Quickly and Easily
10. More Evidence Published That Epidemics of Childhood Obesity, Type 2 Diabetes and Metabolic Syndrome are Linked to Immunization
11. Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk